LifeMD, Inc. (LFMD)Healthcare | Health Information Services | New York, United States | NasdaqGM
3.14 USD
-0.12
(-3.681%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 3.20 +0.06 (1.901%) ⇧ (Aug. 28, 2026, 7:49 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 3:02 a.m. EDT
The investment case for LifeMD is currently broken by deteriorating fundamentals and a lack of capital preservation. Despite a 'strong buy' analyst rating and a lofty price target, the reality on the ground is stark: the company is burning cash, posting negative free cash flow, and recently missed earnings while cutting forward guidance. The balance sheet is fragile with a current ratio below 1.0 and negative returns on equity and assets. While the stock has rallied significantly over the last decade, the most recent annual performance shows continued weakness, and the recent price action confirms a struggle to find support. With no dividend to provide income and a high beta amplifying downside risk, the security offers no margin of safety. The options market agrees, with traders loading up on puts to hedge against further declines. This is a speculative trap where the narrative of potential upside ignores the immediate threat of insolvency. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.098755 |
| AutoARIMA | 0.099438 |
| AutoETS | 0.100422 |
| AutoTheta | 0.141888 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 34% |
| H-stat | 10.26 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.138 |
| Excess Kurtosis | -1.01 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 75.531 |
| Revenue per Share | 4.074 |
| Market Cap | 151,350,624 |
| Forward P/E | 8.26 |
| Beta | 2.06 |
| Profit Margins | 0.10% |
| Previous Name | Conversion Labs, Inc. |
| Website | https://lifemd.com |
As of Aug. 22, 2026, 3:02 a.m. EDT: Speculators are positioning defensively with heavy put volume relative to calls, particularly in the near-to-medium term (Nov 2026 and Jan 2027). Open interest is concentrated significantly out-of-the-money on both sides, suggesting bets on a binary event or a significant gap down rather than a steady grind up. The implied volatility is elevated, reflecting uncertainty about the company's ability to meet revised guidance.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.47163695 |
| Address1 | 236 Fifth Avenue |
| Address2 | Suite 400 |
| All Time High | 33.02 |
| All Time Low | 0.15 |
| Ask | 4.99 |
| Ask Size | 2 |
| Audit Risk | 10 |
| Average Daily Volume10 Day | 498,770 |
| Average Daily Volume3 Month | 942,108 |
| Average Volume | 942,108 |
| Average Volume10Days | 498,770 |
| Beta | 2.061 |
| Bid | 2.78 |
| Bid Size | 2 |
| Board Risk | 7 |
| Book Value | 0.167 |
| City | New York |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.14 |
| Current Ratio | 0.903 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 3.295 |
| Day Low | 3.15 |
| Debt To Equity | 75.531 |
| Display Name | LifeMD |
| Dividend Date | 1,602,633,600 |
| Earnings Call Timestamp End | 1,785,960,000 |
| Earnings Call Timestamp Start | 1,785,960,000 |
| Earnings Timestamp | 1,785,960,000 |
| Earnings Timestamp End | 1,794,254,400 |
| Earnings Timestamp Start | 1,794,254,400 |
| Ebitda | -18,955,210 |
| Ebitda Margins | -0.09894 |
| Enterprise To Ebitda | -6.976 |
| Enterprise To Revenue | 0.69 |
| Enterprise Value | 132,226,280 |
| Eps Current Year | -0.165 |
| Eps Forward | 0.38 |
| Eps Trailing Twelve Months | -0.51 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.9738 |
| Fifty Day Average Change | -0.83379984 |
| Fifty Day Average Change Percent | -0.20982431 |
| Fifty Two Week Change Percent | -47.163696 |
| Fifty Two Week High | 7.32 |
| Fifty Two Week High Change | -4.1800003 |
| Fifty Two Week High Change Percent | -0.5710383 |
| Fifty Two Week Low | 2.56 |
| Fifty Two Week Low Change | 0.58000016 |
| Fifty Two Week Low Change Percent | 0.22656257 |
| Fifty Two Week Range | 2.56 - 7.32 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,201,617,000,000 |
| Float Shares | 39,655,793 |
| Forward Eps | 0.38 |
| Forward P E | 8.263158 |
| Free Cashflow | -14,414,537 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 347 |
| Fullday Change | -0.12 |
| Fullday Change Percent | -3.68098 |
| Fullday Price | 3.1997 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,785,542,400 |
| Gross Margins | 0.875 |
| Gross Profits | 167,642,992 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.14685 |
| Held Percent Institutions | 0.4502 |
| Implied Shares Outstanding | 48,200,837 |
| Industry | Health Information Services |
| Industry Disp | Health Information Services |
| Industry Key | health-information-services |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,602,633,600 |
| Last Split Factor | 1:5 |
| Long Business Summary | LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York. |
| Long Name | LifeMD, Inc. |
| Market | us_market |
| Market Cap | 151,350,624 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_688458 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-08-29 |
| Net Income To Common | -24,870,756 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 157,134,728 |
| Number Of Analyst Opinions | 8 |
| Open | 3.26 |
| Operating Cashflow | -6,691,737 |
| Operating Margins | -0.15079 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Phone | 866 351 5907 |
| Post Market Change | 0.059700012 |
| Post Market Change Percent | 1.9012742 |
| Post Market Price | 3.1997 |
| Post Market Time | 1,787,960,951 |
| Prev Name | Conversion Labs, Inc. |
| Previous Close | 3.26 |
| Price Eps Current Year | -19.030302 |
| Price Hint | 4 |
| Price To Book | 18.802397 |
| Price To Sales Trailing12 Months | 0.7899613 |
| Profit Margins | 0.00105 |
| Quick Ratio | 0.781 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.12 |
| Regular Market Change Percent | -3.68098 |
| Regular Market Day High | 3.295 |
| Regular Market Day Low | 3.14 |
| Regular Market Day Range | 3.14 - 3.295 |
| Regular Market Open | 3.26 |
| Regular Market Previous Close | 3.26 |
| Regular Market Price | 3.14 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 465,841 |
| Return On Assets | -0.1892 |
| Return On Equity | -5.15898 |
| Revenue Growth | -0.035 |
| Revenue Per Share | 4.074 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 3 |
| Shares Outstanding | 48,200,837 |
| Shares Percent Shares Out | 0.1441 |
| Shares Short | 6,946,743 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 7,125,889 |
| Short Name | LifeMD, Inc. |
| Short Percent Of Float | 0.1725 |
| Short Ratio | 6.58 |
| Source Interval | 15 |
| State | NY |
| Symbol | LFMD |
| Target High Price | 15.0 |
| Target Low Price | 5.0 |
| Target Mean Price | 8.125 |
| Target Median Price | 7.5 |
| Total Cash | 25,141,616 |
| Total Cash Per Share | 0.522 |
| Total Debt | 6,017,124 |
| Total Revenue | 191,592,464 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.51 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.90385 |
| Two Hundred Day Average Change | -0.76385 |
| Two Hundred Day Average Change Percent | -0.1956658 |
| Type Disp | Equity |
| Volume | 465,841 |
| Website | https://lifemd.com |
| Zip | 10,001 |